Agenus
(NASDAQ) AGEN
Agenus Financials at a Glance
Market Cap
$134.92MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$123.87M
Net Income (TTM)
$64.61M
EPS (TTM)
$1.67
P/E Ratio
1.94
Dividend
$0.00
Beta (Volatility)
1.82 (High)
Dividend
$0.00
Beta (Volatility)
1.82 (High)
Price
$3.24
Volume
654,170.556
Open
$3.25
Price
$3.24
Volume
654,170.556
Open
$3.25
Previous Close
$3.24
Daily Range
$3.19 - $3.35
52-Week Range
$2.71 - $7.34
Estimated Earnings Date
Aug 10, 2026
Dividend
$0.00
Beta (Volatility)
1.82 (High)
Price
$3.24
Volume
654,170.556
Open
$3.25
Previous Close
$3.24
Daily Range
$3.19 - $3.35
52-Week Range
$2.71 - $7.34
Estimated Earnings Date
Aug 10, 2026
AGEN News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Agenus
Industry
Biotechnology
Sector
Health CareEmployees
81
CEO
Garo H. Armen, PhD
Website
www.agenusbio.comHeadquarters
Lexington, MA 02421-7305, US
AGEN Financials
Key Financial Metrics (TTM)
Gross Margin
52.14%
Operating Margin
6.62%
Net Income Margin
52.16%
Return on Equity
-23.05%
Return on Capital
-32.23%
Return on Assets
34.65%
Earnings Yield
51.55%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$134.92MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
41.64M
Volume
654.17K
Avg. Volume
897.89K
Financials (TTM)
Gross Profit
$64.58M
Operating Income
$8.20M
EBITDA
$127.04M
Operating Cash Flow
-$87.53M
Capital Expenditure
-$1.00K
Free Cash Flow
-$87.53M
Cash & ST Invst.
$35.00M
Total Debt
$304.46M
Agenus Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$33.74M
+40.2%
Gross Profit
$33.15M
+1277.4%
Gross Margin
98.27%
N/A
Market Cap
$134.92MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$1.67M
N/A
Employees
81
N/A
Net Income
$39.23M
+255.3%
EBITDA
$54.48M
+625.3%
Quarterly Fundamentals
Total Cash
$35.00M
+89.3%
Total Debt
$304.46M
+230.8%
Accounts Receivable
$54.06M
+15171.8%
Inventory
$0.00
N/A
Long Term Debt
$163.81M
+88.7%
Short Term Debt
$140.65M
+2597.1%
Return on Assets
34.65%
N/A
Return on Invested Capital
-13.05%
N/A
Free Cash Flow
-$35.95M
-40.3%
Operating Cash Flow
-$35.95M
-40.3%